Logo Image

Authors

Marc R. Nuwer, MD, PhD
Latest Article

Marc Nuwer Explores the 2019 CPT Codes for Epilepsy

The professor and vice chair of the neurology department at UCLA discussed the new VNS, RNS and DBS CPT codes for 2019.

Clyde E. Markowitz, MD, Patricia K. Coyle, MD
Peter Goadsby, MBBS
Chris Mazzolini
Latest Article

Eight Ways to Evaluate a Telehealth Vendor

A look at the questions you should be asking during the decision-making process of picking a telehealth vendor.

Leslie Humbel, BA
Latest Article

Spinal Muscular Atrophy and COVID-19: Guidance and Resources for Providers

Advocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.

Jill Jarecki, PhD
Latest Article

Spinal Muscular Atrophy and COVID-19: Guidance and Resources for Providers

Advocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.

Rohit Dhall, MD, MSPH
Latest Article

Noninvasive Neuromodulation for Essential Tremor: An Important Tool for Maintaining Independence at Home

Noninvasive neuromodulation with TAPS is a safe and effective tool that offers particular utility in the age of COVID-19 when other treatment options may be less accessible.

Staff Writer
Latest Article

Gene Therapy Shows Robust Activity for Duchenne Muscular Dystrophy

A novel gene therapy has demonstrated impressive early results in a small sample of 3 children with Duchenne muscular dystrophy.

Mazen Hanna, MD
Stephen Silberstein, MD, Richard B. Lipton, MD
Stephen Silberstein, MD, Peter Goadsby, MBBS
Amy Harper, MD
Richard B. Lipton, MD, Stephen Silberstein, MD
David K. B. Li, MD, FRCPC
Latest Article

The Importance of a Globally Aligned, Standardized MRI Protocol for MS

Leaders of the CMSC Working Group on MRI protocols and clinical guidelines express the need for a unified approach to diagnosing and monitoring multiple sclerosis.

Richard Trosh, MD
Aaron Boster, MD
Latest Article

Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction

Both the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management.

Sebastian Mills
Suhayl S. Dhib-Jalbut, MD
Kenneth Bender, PharmD, MA
Latest Article

The “Grave Threat” Posed by the Shortage of Neurologists

With the physician deficit projected to grow larger within a decade, this global challenge has become a major focus of large organizations and medical societies.

Rod Foroozan, MD
Ashley Aaroe, MD
Latest Article

Neurology on the Hill: My Role as an Advocate for Neurology

Neuro-oncology fellow Ashley Aaroe recounts her experience at Neurology on the Hill, advocating for important changes in neurology health care.

Rodney A. Radtke, MD
Erica Slaughter, MS
Latest Article

Managing Psychosis in Parkinson Disease: Challenges and Opportunities

Although the indication of pimavanserin has provided some relief, more work remains to improve how physicians diagnose, treat, and manage psychosis symptoms.

Suhayl Dhib-Jalbut, MD

Chief of Neurology at Robert Wood Johnson University Hospital and Chair of Neurology at Rutgers Robert Wood Johnson Medical School and Rutgers Medical School of New Jersey in New Brunswick.

Latest Article

Study Findings Provide New Hope for Patients With Multiple Sclerosis

Multiple sclerosis affects nearly 3 million patients worldwide; new research is helping pave the way for developing new therapies and medications that get at the defining mechanisms that trigger immune regulation loss of this unpredictable central nervous system disease.

Matthew J. Baker, MD
James W. Kupiec, MD
Latest Article

Aducanumab's Unlikely Road to the FDA: Is Approval Imminent?

Recent news that the FDA has granted the fastest possible review for Biogen’s Alzheimer disease treatment aducanumab may be indicative of the agency’s increasing confidence in the drug.

David Bai, PharmD
Latest Article

What You Need to Know About Amantadine for Parkinson Disease

This guide includes everything you need to know about amantadine (Osmolex ER, Osmotica Pharmaceuticals) for the treatment of Parkinson disease and drug-induced extrapyramidal reactions in adults.

Eveline Honig, MD, MPH
Peter LeWitt, MD, M.Med.Sc
Will Pass, DVM
Latest Article

Sigma-1 Agonists Offer Combination Approach to Dementia Symptoms

Research from the past decade suggests that sigma-1 receptors and their encoding gene, SIGMAR1, together act as a therapeutic target for patients with dementia.